• Home
  • Site Map
  • Privacy Policy
  •  

    Only ZEGERID offers a unique pharmacokinetic profile for IMMEDIATE RELEASE1,3-9

    ZEGERID® (omeprazole/sodium bicarbonate) has a unique pharmacokinetic profile. Delayed-release omeprazole products or formulations are not therapeutically equivalent to ZEGERID.

    • ZEGERID is not therapeutically equivalent to Prilosec®, Prilosec OTC®, or generic omeprazole.1
    • There are no AB-rated generic equivalents to ZEGERID according to the FDA Orange Book.2
    • All other oral PPIs are delayed-release and require enteric coatings that delay absorption and initial acid suppression.3-8

    Only ZEGERID has a built-in buffer to protect the omeprazole, allowing for peak plasma levels in ~30 minutes. Learn more about the unique immediate-release technology of ZEGERID.

    Next: Ordering ZEGERID

    References
    1. ZEGERID Prescribing Information. Santarus, Inc. January 2010.
    2. FDA website. Electronic Orange Book. Available at: www.fda.gov/cder/ob/default.htm.
      Accessed May 27, 2010.
    3. Castell D. Review of immediate-release omeprazole for the treatment of gastric acid-related disorders.
      Expert Opin Pharmacother. 2005;6;2501-2510.
    4. Aciphex Prescribing Information. Eisai Inc. and Janssen Pharmaceutica Inc. January 2009.
    5. Nexium Prescribing Information. AstraZeneca. June 2009.
    6. Prevacid Prescribing Information. TAP Pharmaceutical Products, Inc. May 2009.
    7. Prilosec Prescribing Information. AstraZeneca. March 2010.
    8. Protonix Prescribing Information. Wyeth Pharmaceuticals, Inc. December 2009.
    9. Dexilant Prescribing Information. Takeda Pharmaceuticals America, Inc. March 2010.